DIrect Effect of DPP-4 inhibitor on HbA1c levels and Renal Dysfunction
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
Price : $35 *
At a glance
- Drugs Teneligliptin (Primary) ; Sitagliptin
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 08 Sep 2014 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan record.
- 22 Oct 2013 New trial record